Volume 5, Number 3—June 1999
Synopsis
Emergence of a Unique Group of Necrotizing Mycobacterial Diseases
Karen M. Dobos*†, Frederick D. Quinn†, David A. Ashford†, C. Robert Horsburgh*, and C. Harold King*
Table 3
Laboratory-confirmed cases of Mycobacterium marinum reported by individual states within the United States, by year, 1993–1996a
| No. cases (%)b |
|||||
|---|---|---|---|---|---|
| State | 1993 | 1994 | 1995 | 1996 | |
| Florida | 15 (9.9) | 13 (7.3) | 13 (8.8) | 24 (15.3) | |
| Maryland | 15 (9.9) | 24 (13.4) | 21 (14.3) | 22 (14.0) | |
| Minnesota | 6 (4.0) | 4 (2.2) | 6 (4.1) | 8 (5.1) | |
| Missouri | 2 (1.3) | 7 (3.9) | 5 (3.4) | 9 (5.7) | |
| Utah | 3 (1.9) | 2 (1.1) | 5 (3.4) | 4 (2.6) | |
| Virginia | 7 (4.6) | 13 (7.3) | 12 (8.2) | 11 (7.0) | |
| Wisconsin | 9 (5.9) | 8 (4.5) | 9 (6.1) | 9 (5.7) | |
aThese data are reported as part of the passive laboratory-based surveillance system using the Public Health Laboratory Information System software developed by the Centers for Disease Control and Prevention and the Association of State and Territorial Public Health Laboratory Directors.
bPercent (%) denotes contribution to cases reported nationally for the year.
Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.